SII restarts manufacturing of COVISHIELD PTI Apr 14, 2023 Adar Poonawalla informs that the company already has six million booster doses of Covovax vaccine available and adults must take…
SII seeks inclusion of COVID jab Covovax in CoWIN portal as heterologous booster dose for adults PTI Jan 19, 2023 The National Technical Advisery Group on Immunisation (NTAGI) is likely to hold a meeting soon to decide on the matter
DCGI approves market authorisation for SII’s COVID vaccine Covovax as heterologous booster… PTI Jan 17, 2023 The DCGI's approval came following recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control…
COVID-19: Covovax to get approval as booster in 10-15 days: Adar Poonawalla PTI Jan 11, 2023 He said everyone was looking at India, not just in terms of healthcare, but because the country managed to take care of a huge and…
Serum Institute seeks drug regulator’s approval for market authorisation of its COVID vaccine as… PTI Dec 23, 2022 The vaccine will be administered to those aged 18 years and above, and those who have been administered two doses of Covishield or…
Serum Institute seeks nod to export 32.4 lakh doses of its COVID vaccine Covovax to US Press Trust of India Jul 4, 2022 It will be the first vaccine to be exported to the country by any Indian manufacturer, according to official sources
Government panel recommends emergency approval for SII’s Covovax for seven-11 year olds Press Trust of India Jun 27, 2022 The recommendation has been sent to the Drugs Controller General of India (DCGI) for final approval
DCGI panel to review today SII applications for Covovax’s use among kids aged 2-7 years, 7-11… Press Trust of India Jun 24, 2022 The expert panel in its last meeting in April had sought more data from SII following its application seeking the Emergency Use…
SII lowers price of each dose of Covovax jab from Rs 900 to Rs 225 Press Trust of India May 4, 2022 The firm is reducing the price of each dose from Rs 900 to Rs 225 plus Goods and Services Tax (GST) for private hospitals. In…
NTAGI panel recommends Covovax in vaccination drive for 12-17 years’ age group Press Trust of India May 2, 2022 India's drug regulator had approved Covovax for restricted use in emergency situations in adults on 28th December last year and in…